3 Reasons to Buy Eli Lilly Stock | The Motley Fool

Aug 16, 2023 · All in all, Eli Lilly's stock is up nearly 75% in the trailing-12-month period, bringing its market capitalization to about $500 billion. That's well into mega-cap territory.

75%
OFF

3 Reasons To Buy Eli Lilly Stock | The Motley Fool

2 weeks from now

Aug 16, 2023 · All in all, Eli Lilly's stock is up nearly 75% in the trailing-12-month period, bringing its market capitalization to about $500 billion. That's well into mega-cap territory.

fool.com

$434
OFF

3 Reasons To Buy Eli Lilly, And 1 Reason To Sell | The Motley Fool

2 weeks from now

Eli Lilly's existing drugs can power near-term growth. Eli Lilly's $434 billion market … Eli Lilly's drug pipeline could deliver lasting growth. Eli Lilly has what it takes to sustain this … Eli Lilly has a modest dividend with rapid growth potential. Stacked against the S&P 500 …

fool.com

61%
OFF

15 Billion Reasons To Love Eli Lilly Stock Right Now

2 weeks from now

Dec 17, 2024 · Pharmaceutical giant Eli Lilly (LLY 1.61%) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two …

fool.com

20%
OFF

Eli Lilly Just Got A Bundle Of Good News: Time To Buy?

2 weeks from now

Dec 4, 2024 · Plenty of reasons to buy. Eli Lilly's shares recently dropped after its third-quarter results did not meet expectations. The company's revenue increased by 20% year over year to …

fool.com

61%
OFF

2 Brand-New Reasons To Buy Eli Lilly Stock Right Now ... - The …

2 weeks from now

Dec 15, 2024 · As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (LLY 1.61%) is always providing investors with additional reasons to …

fool.com

$141
OFF

Prediction: These 3 Healthcare Stocks Will Soar In 2025

2 weeks from now

Jan 4, 2025 · Motley Fool Issues Rare “All In” Buy Alert. NASDAQ: AMGN Amgen. Market Cap. $141B. Today's Change ... With all that going Eli Lilly's way, the stock could once again deliver …

fool.com

27%
OFF

Why Eli Lilly, Novo Nordisk, And Viking Therapeutics ... - The …

2 weeks from now

6 hours ago · Bad news for Eli Lilly (LLY-7.27%) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated investors on its expected revenue …

fool.com

$5000
OFF

Got $5,000? These 3 Growth Stocks Are Trading Near ... - The …

2 weeks from now

23 hours ago · That puts it in the same ballpark as Eli Lilly and Novo Nordisk, ... Amgen may be the most attractively valued GLP-1 stock to buy right now. 3. Prologis ... Invest better with The …

fool.com

75%
OFF

3 Reasons To Buy Eli Lilly Stock - The Globe And Mail

2 weeks from now

Aug 16, 2023 · All in all, Eli Lilly's stock is up nearly 75% in the trailing-12-month period, bringing its market capitalization to about $500 billion. That's well into mega-cap territory.

theglobeandmail.com

5%
OFF

After It Drops 13.5% In A Day, Is It Time I Bought This S&P ... - Fool UK

2 weeks from now

Oct 30, 2024 · I owned Eli Lilly stock a while back. However, I sold after it doubled in a year and the price-to-earnings (P/E) multiple went well above 100. Currently though, the forward P/E …

fool.co.uk

17%
OFF

Eli Lilly Stock: 4 Reasons To Buy The Dip After A 17% Drop

2 weeks from now

1 day ago · Eli Lilly & Co. NYSE: LLY is a major global pharmaceutical company in the medical sector.The company made headlines with its dominant GLP-1 drug, Tirzepatide, sold as …

marketbeat.com

8%
OFF

2 Excellent Dividend Stocks To Buy On The Dip | The Motley Fool

2 weeks from now

Dec 23, 2024 · The stock's forward yield is now around 3.8%, compared to the S&P 500's average of 1.3%. So despite its recent issues, AbbVie should continue to deliver strong returns …

fool.com

FAQs about 3 Reasons to Buy Eli Lilly Stock | The Motley Fool Coupon?

Is Eli Lilly (LLY) a good stock to buy?

Eli Lilly ( LLY -0.64%) has been one of the better-performing pharma companies of 2020. Year to date, the pharma giant's stock is up by 24.7%, while the SPDR S&P Pharmaceuticals ETF -- an industry benchmark -- is down by 5.5%. There are several reasons Eli Lilly has been beating the market of late. ...

Should you buy Eli Lilly?

They're also each other's biggest rivals, especially in the all-important market for weight-loss drugs, in which both are currently highly successful. Right now, there are a few reasons to believe that Eli Lilly has the upper hand in this competitive clash. Those reasons support buying its stock, assuming you don't want to invest in both companies. ...

Is Eli Lilly profitable?

Eli Lilly is not only profitable, but the business also generates a ton of free cash flow -- some $5.3 billion over the trailing 12 months. That can help the company pay dividends, buy back shares, and invest in the business itself. And Eli Lilly has been doing all of that: Image source: Eli Lilly Q3 earnings presentation. ...

Is Eli Lilly stock undervalued?

Eli Lilly has become one of the world's most influential pharmaceutical companies. That's thanks to its weight-loss medications, but it has other opportunities now as well. A recent announcement from the company suggests the stock is undervalued. Lilly just gave investors more reasons to cheer the company on. ...

Should you buy Eli Lilly (LLY -0.35%)?

Lilly just gave investors more reasons to cheer the company on. Pharmaceutical giant Eli Lilly (LLY -0.35%) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster diabetes and obesity care medications, Mounjaro and Zepbound. ...

Is Eli Lilly outperforming the market?

Eli Lilly has been outperforming — and could continue to outperform — the market. Eli Lilly ( LLY -0.64%) has been one of the better-performing pharma companies of 2020. Year to date, the pharma giant's stock is up by 24.7%, while the SPDR S&P Pharmaceuticals ETF -- an industry benchmark -- is down by 5.5%. ...